← All diseases
Liver, kidneys and digestion
Fatty liver disease (MASH/NASH), advanced
Do you want to receive a message when there is new research about Liver Fat (MASH/NASH), advanced? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, a single sentence appears above each publication explaining what was studied — and you'll be notified as soon as new research on Liver Steatosis (MASH/NASH), Advanced is available. View what Premium costs.
Publications and studies (2550)
- Suppressive effect of nobiletin and epicatechin gallate on fructose uptake in human intestinal epithelial Caco-2 cells. (2018/04/01) ♡
- How bariatric surgery affects liver volume and fat density in NAFLD patients. (2018/04/01) ♡
- Response to Pioglitazone in Patients With Nonalcoholic Steatohepatitis With vs Without Type 2 Diabetes. (2018/04/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Non-alcoholic fatty liver disease: A risk factor for myocardial dysfunction? (2018/04/01) ♡
- Hitting a triple in the non-alcoholic fatty liver disease field: sucrose intake in adulthood increases fat content in the female but not in the male rat offspring of dams fed a gestational low-protein diet. (2018/04/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Reply. (2018/04/01) ♡
- Age-dependent alterations of glucose clearance and homeostasis are temporally separated and modulated by dietary fat. (2018/04/01) ♡
- Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice. (2018/04/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver. (2018/04/01) ♡
- Maternal betaine supplementation attenuates glucocorticoid-induced hepatic lipid accumulation through epigenetic modification in adult offspring rats. (2018/04/01) ♡
- Effect of longitudinal changes of body fat on the incidence and regression of nonalcoholic fatty liver disease. (2018/04/01) ♡
- Nonalcoholic fatty liver disease as a sentinel marker for the development of diabetes mellitus in non-obese subjects. (2018/04/01) ♡
- Protective effect of black relative to white race against non-alcoholic fatty liver disease in patients with severe obesity, independent of type 2 diabetes. (2018/04/01) ♡
- Gut microbiome composition in lean patients with NASH is associated with liver damage independent of caloric intake: A prospective pilot study. (2018/04/01) ♡
- Mulberry Leaf Extracts prevent obesity-induced NAFLD with regulating adipocytokines, inflammation and oxidative stress. (2018/04/01) ♡
- Non-invasive markers of liver fibrosis in fatty liver disease are unreliable in people of South Asian descent. (2018/04/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: A clinical review. (2018/04/01) ♡
- [Ginseng prescription rules and molecular mechanism in treating coronary heart disease based on data mining and integrative pharmacology]. (2018/04/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. An in vitro and in vivo study of a 4-herb formula on the management of diet-induced metabolic syndrome. (2018/03/15) ♡
- Autophagy activation by Jiang Zhi Granule protects against metabolic stress-induced hepatocyte injury. (2018/03/07) ♡
- Green tea extract protects against hepatic NFκB activation along the gut-liver axis in diet-induced obese mice with nonalcoholic steatohepatitis by reducing endotoxin and TLR4/MyD88 signaling. (2018/03/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Cadmium exposure exacerbates severe hyperlipidemia and fatty liver changes in zebrafish via impairment of high-density lipoproteins functionality. (2018/03/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Myeloid deficiency of CCN3 exacerbates liver injury in a mouse model of nonalcoholic fatty liver disease. (2018/03/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Knockout of l-Histidine Decarboxylase Prevents Cholangiocyte Damage and Hepatic Fibrosis in Mice Subjected to High-Fat Diet Feeding via Disrupted Histamine/Leptin Signaling. (2018/03/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Mesenchymal stem cells reverse high‑fat diet‑induced non‑alcoholic fatty liver disease through suppression of CD4+ T lymphocytes in mice. (2018/03/01) ♡
- Activin-A causes Hepatic stellate cell activation via the induction of TNFα and TGFβ in Kupffer cells. (2018/03/01) ♡
- Role of PTP1B in POMC neurons during chronic high-fat diet: sex differences in regulation of liver lipids and glucose tolerance. (2018/03/01) ♡
- Differing clinical phenotype for higher alanine-aminotransferase (ALT) compared with high-risk NAFLD fibrosis score in type 2 diabetes mellitus. (2018/03/01) ♡
- Patients with clinically metabolically healthy obesity are not necessarily healthy subclinically: further support for bariatric surgery in patients without metabolic disease? (2018/03/01) ♡
- Natural products berberine and curcumin exhibited better ameliorative effects on rats with non-alcohol fatty liver disease than lovastatin. (2018/03/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. CGplus, a standardized herbal composition ameliorates non-alcoholic steatohepatitis in a tunicamycin-induced mouse model. (2018/03/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Isobaric tags for relative and absolute quantitation (iTRAQ)-based proteomics for the investigation of the effect of Hugan Qingzhi on non-alcoholic fatty liver disease in rats. (2018/02/15) ♡
- Intrahepatic cholestasis in nonalcoholic fatty liver disease. (2018/02/15) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Clinical-morphological parallels of the PNPLA3 gene polymorphism in patients with nonalcoholic fatty liver disease. (2018/02/15) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Optimizing therapy of liver diseases not associated with viral infection. (2018/02/15) ♡
- Hepatoprotective Effects of a Functional Formula of Three Chinese Medicinal Herbs: Experimental Evidence and Network Pharmacology-Based Identification of Mechanism of Action and Potential Bioactive Components. (2018/02/07) ♡
- DHA supplementation prevent the progression of NASH via GPR120 signaling. (2018/02/05) ♡
- Euterpe oleracea Mart. (açaí) seed extract associated with exercise training reduces hepatic steatosis in type 2 diabetic male rats. (2018/02/01) ♡
- Dietary omega-3 and omega-6 polyunsaturated fatty acids modulate hepatic pathology. (2018/02/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Parenteral Soybean Oil Induces Hepatosteatosis Despite Addition of Fish Oil in a Mouse Model of Intestinal Failure-Associated Liver Disease. (2018/02/01) ♡
- Using an Allometric Equation to Accurately Predict the Energy Expenditure of Children and Adolescents With Nonalcoholic Fatty Liver Disease. (2018/02/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Genipin alleviates high-fat diet-induced hyperlipidemia and hepatic lipid accumulation in mice via miR-142a-5p/SREBP-1c axis. (2018/02/01) ♡
- Adipocyte JAK2 Regulates Hepatic Insulin Sensitivity Independently of Body Composition, Liver Lipid Content, and Hepatic Insulin Signaling. (2018/02/01) ♡
- Diosgenin prevents high-fat diet-induced rat non-alcoholic fatty liver disease through the AMPK and LXR signaling pathways. (2018/02/01) ♡
- Early Clinical Expressions of Insulin Resistance: The Real Enemy to Look For. (2018/02/01) ♡
- Activation of hepatic Nogo-B receptor expression-A new anti-liver steatosis mechanism of statins. (2018/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. A critical review of endpoints for non-cirrhotic NASH therapeutic trials. (2018/02/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. NAFLD: The evolving landscape. (2018/02/01) ♡
- Baicalin attenuates diet induced nonalcoholic steatohepatitis by inhibiting inflammation and oxidative stress via suppressing JNK signaling pathways. (2018/02/01) ♡
- SREBP‑2 expression pattern contributes to susceptibility of Mongolian gerbils to hypercholesterolemia. (2018/02/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.